FDA Brief

Company record

Preferred Pharmaceuticals, Inc.

0 FDA warning letters since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Preferred Pharmaceuticals, Inc..

Recalls

ReportedClassFirmProduct and reason
Nov 11 Class II Preferred Pharmaceuticals, Inc.
Drug
Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0
Lack of Assurance of Sterility
Oct 14 Class II Preferred Pharmaceuticals, Inc.
Drug
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Failed Content Uniformity Specifications
Apr 15 Class II Preferred Pharmaceuticals, Inc.
Drug
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Lack of Assurance of Sterility
Dec 24, 2025 Class II Preferred Pharmaceuticals, Inc.
Drug
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.